For instance, anti-tuberculosis drugs isoniazid and ethionamide have been proven to inhibit the biosynthesis of mycolic acids (Table 1) and exert their function by inactivating the reductase activity of the enoyl-acyl-carrier protein (InhA). This evidence concerns the gene INHA and tuberculosis.